Elizabetta Patorno, Comparative Gastrointestinal Safety of Dulaglutide, Semaglutide, and Tirzepatide in Adults With Type 2 Diabetes November 23, 2025- Medical malpractice lawsuit related to GLP-1 scripts A victim who lost dozens of pounds rapidly using GLP-1 medications , constituting half of his body weight, filed a med mal lawsuit against his physician alleging awful complications and debilitating injuries
Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): A multicentre, randomised, double-blind, placebo-controlled phase 3 trial
Instead, the goal is to eliminate major exposures and support our body's ability to detoxify smaller& exposures so they don't negatively impact our health
[3] This is crucial because muscle tissue is metabolically active, helping to maintain a higher resting metabolic rate